Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-20-049578

Director sold 7,360 shares at an average $4.01 ($29,513)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CLARKE JOHN K Director 2020-08-28 Sale −100 $4.00 $400 117,843 I
CLARKE JOHN K Director 2020-09-02 Sale −7,260 $4.01 $29,113 110,583 I
Open-market sales · 7,360 sh · avg $4.01 · $29,513
Loading xslF345X03/doc4.xml…